Xanthan Gum

1. INCI et CAS

INCI: Xanthan Gum · CAS: 11138-66-2

2. Rôle dans la formule

Xanthan is the standard polysaccharide stabilizer. It is not a film drug.

3. Niveaux d'emploi typiques (repère de formulation)

• Emulsions: 0.15–0.4%

Pre-disperse in glycerin.

4. Sources réglementaires et conformité mondiale

• The CosIng record for Xanthan Gum, where listed, is informational rather than product-specific authorization.
• The framework in Regulation (EC) No 1223/2009 requires the complete cosmetic containing Xanthan Gum to receive its own safety assessment for the complete formula intended for sale.
• Match the selected Xanthan Gum material to its supplier TDS and check the filing list for the market of sale.

5. Sécurité et évaluation des risques

The listed use rate is intended as a cosmetic-development guide; it does not qualify a finished product as a drug or OTC product and patch and stability testing remain part of finished-product review.

6. Stabilité et conditionnement

Use cool, sealed storage away from strong light for the bulk; match the pack choice to the system's oxidation risk; check the finished batch's stability and package compatibility.

7. Formulations d'allégations (à faire / à éviter)

• Supports an emulsion-stabilizer story

• This reference is not evidence of therapeutic effects, curative outcomes, or unsupported certification statements.
• The formulation record for Xanthan Gum cannot establish whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.

1. INCI et CAS

INCI: Glycerin · CAS: 56-81-5

2. Rôle dans la formule

Glycerin serves as the polyol humectant in these cosmetic formats, while the stated percentage remains a formulation reference.

3. Niveaux d'emploi typiques (repère de formulation)

• Formulation guidance for gels and serums: 3–8%.
• For creams, the reference gives 2–5%.
• Formulation guidance for rinse-off: 2–4% as a formulation guide.

The water phase is the addition point for Glycerin; a separate melt is unnecessary.

4. Sources réglementaires et conformité mondiale

• Use CosIng's information on Glycerin as a reference, then verify the specific grade and intended use under market rules.
• The finished-product provisions of Regulation (EC) No 1223/2009 require the final cosmetic with Glycerin to undergo a safety assessment for the specific product as it will be marketed.
• Establish grade-specific details for Glycerin from the supplier and assess filing requirements in the intended market.

5. Sécurité et évaluation des risques

Use the stated level as reference guidance for cosmetic formulation; no drug approval or OTC status is conferred by this entry with patch response and finished-product stability still to be verified.

6. Stabilité et conditionnement

Store sealed bulk away from heat and sunlight; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; then verify formula stability and pack compatibility on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• This guide frames Glycerin's cosmetic direction around humectant function.

• The listed information does not demonstrate claims of drug activity, a clinical cure, or an undocumented product certification.
• The documented facts for Glycerin does not demonstrate whitening, acne treatment, antiperspirant effects, sunscreen use, or hair growth.

1. INCI et CAS

INCI: Squalane · CAS: 111-01-3

2. Rôle dans la formule

The guide uses plant-derived squalane, a stable hydrocarbon emollient, and does not specify mineral oil.

3. Niveaux d'emploi typiques (repère de formulation)

• For gel-creams, the reference gives 2–6% in this reference.
• For dry oils, the reference gives 10–30% as a formulation guide.
• The stated reference for balms is 5–15% for the formula.

Add Squalane to the oil phase; no high-shear wax step is required.

4. Sources réglementaires et conformité mondiale

• CosIng information about Squalane does not itself authorize a particular grade or finished cosmetic.
• The EU Cosmetics Regulation (EC) No 1223/2009 requires the complete cosmetic containing Squalane to receive its own safety assessment before release of the finished cosmetic.
• Compare the received Squalane material with its supplier specification and review destination-market filing needs.

5. Sécurité et évaluation des risques

The listed use rate is intended as a cosmetic-development guide; it is not evidence of drug approval or OTC authorization so assess patch response and stability in the final formula.

6. Stabilité et conditionnement

Store the bulk in a closed container in a cool, shaded place; if oxidation risk calls for it, review a pump or airless format; then verify formula stability and pack compatibility on the confirmed batch.

7. Formulations d'allégations (à faire / à éviter)

• The listed cosmetic direction for Squalane emphasizes a light-emollient role.

• The available ingredient details does not demonstrate drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• The ingredient record for Squalane offers no support for whitening, treatment of acne, perspiration control, sun protection, or hair growth.